Biography
Dr. James Pingpank is the Director of the Peritoneal Surface Malignancy Program at UPMC Hillman Cancer Center in Pittsburgh, Pennsylvania. With more than a decade of dedicated experience treating peritoneal mesothelioma, he has established one of the most active HIPEC programs in the region. Dr. Pingpank trained in surgical oncology at the National Cancer Institute and performs cytoreductive surgery combined with HIPEC for patients with peritoneal mesothelioma. His program at UPMC Hillman offers comprehensive multidisciplinary care for this rare abdominal cancer.
Education & Training
- Medical Degree — University of Pittsburgh School of Medicine (Medicine)
- Residency — Johns Hopkins Hospital (General Surgery)
- Fellowship — National Cancer Institute (Surgical Oncology)
Specialties & Procedures
Clinical Specialties
- Surgical Oncology
- Peritoneal Surface Malignancies
- HIPEC
Surgical Procedures
Board Certifications
- American Board of Surgery
Research Focus
Peritoneal mesothelioma treatment, cytoreductive surgery with HIPEC, and outcomes optimization for peritoneal surface malignancies.
Legal Resources for Mesothelioma Patients
Patients diagnosed with mesothelioma after asbestos exposure may be eligible for compensation through asbestos trust funds and legal claims. Over $30 billion remains available in trust funds nationwide.
Frequently Asked Questions
How experienced is Dr. Pingpank with peritoneal mesothelioma?
Dr. Pingpank has more than 10 years of dedicated experience treating peritoneal mesothelioma and directing the Peritoneal Surface Malignancy Program at UPMC Hillman. He trained in surgical oncology at the National Cancer Institute.